Branko Kopjar

faculty photo
Associate Professor, Health Services


PhD   University of Oslo (Norway), 1996   (Epidemiology)
MS   University of Zagreb (Yugoslavia), 1991   (Biostatistics)
MD   University of Zagreb (Yugoslavia), 1987   (Internal Medicine)

Contact Info


4333 Brooklyn Ave NE, Rm 14-315
Seattle, WA 98195-9455

campus box:   359455
voice:   206-221-3349
fax:   206-543-3964


Dr. Kopjar is an internationally recognized scholar and expert in biostatistics and clinical epidemiology. He serves as an author/co-author on over 500 published original articles, reviews, technical reports and abstracts. His research interests include: spinal cord injury and diseases, neurosurgery, orthopaedics, preventive medicine and healthcare reform. Dr. Kopjar has been actively participating in the design, management and analysis of clinical trials and medical research for more than 30 years. He is a frequent contributor to such peer-reviewed publications as the Journal of Neurosurgery, the American Journal of Public Health, Spine and the Journal of Bone and Joint Surgery. In the 1990’s he served as the research director for the Norwegian Foundation for Health Services Research and department head of the Section for Preventive Medicine at the Norwegian National Institute of Public Health. As a consultant, he works closely with the leading global pharmaceutical, medical device and venture capital firms in regards to determining the efficacy, safety and investment value of medical technologies. Dr. Kopjar is active in a variety of research organizations including: AOSpine North America, The North American Spine Society (NASS), Cervical Spine Research Society (CSRS) and the International Scholarly Research Network (ISRN). He serves on the editorial board and as a reviewer for a number of academic journals and he is the current director of the Executive Master of Public Health program at the University of Washington. Dr. Kopjar holds the title of Distinguished Professor at Chongqing University in China. In the 2000's he held the title of Adviser to the Minister of Health for two European governments. He is a past recipient of the prestigious John M. Eisenberg Article-of-the-Year award.

Prevention effectiveness; outcomes research; comparative effectiveness; neurosurgery; orthopedics, biostatistics; quality of care; clinical trials

  • HSERV 522   (eMPH)
    Health Program Evaluation
  • HSMGMT 501
    Epidemiology/Critical Evidence Appraisal
  • HSMGMT 501   (EMHA)
    Epidemiology/Critical Evidence Appraisal
  • HSMGMT 501   (MHIHIM)
    Epidemiology/Critical Evidence Appraisal

Fehlings MG, Ibrahim A, Tetreault L, Albanese V, Alvarado M, Arnold P, Barbagallo G, Bartels R, Bolger C, Defino H, Kale S, Massicotte E, Moraes O, Scerrati M, Tan G, Tanaka M, Toyone T, Yukawa Y, Zhou Q, Zileli M, Kopjar B. A Global Perspective on the Outcomes of Surgical Decompression in Patients with Cervical Spondylotic Myelopathy: Results from the Prospective Multicenter AOSpine International Study on 479 patients. Spine (Phila Pa 1976). 2015 May 27. [Epub ahead of print]  PMID: 26020847

Nater-Goulet A, Fehlings MG, Tetreault L, Kopjar B, Arnold PM, Dekutoski MB, Finkelstein J, Fisher C, France J, Gokaslan ZL, Rhines LD, Rose P, Schuster JM. 169?Prognostic Factors for Survival in Surgical Series of Symptomatic Metastatic Epidural Spinal Cord Compression: A Prospective North American Multicenter Study in 145 Patients. Neurosurgery. 2015 Aug;62 Suppl 1:221-2. doi: 10.1227/01.neu.0000467133.05150.0a.  PMID: 26182015

Fehlings MG, Nakashima H, Nagoshi N, Chow DS, Grossman RG, Kopjar B. Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial. Spinal Cord. 2015 Jun 23. doi: 10.1038/sc.2015.95. [Epub ahead of print]  PMID: 26099215

Tetreault L, Côté P, Kopjar B, Arnold P, Fehlings MG; investigators in the AOSpine North America and International Clinical Trial Research Network. A Clinical Prediction Model to Assess Surgical Outcome in Patients with Cervical Spondylotic Myelopathy: Internal and External Validation using the Prospective Multicenter AOSpine North American and International Datasets of 743 Patients. Spine J. 2014 Dec 27. pii: S1529-9430(14)02001-4. doi: 10.1016/j.spinee.2014.12.145. [Epub ahead of print]  PMID: 25549860

Kopjar B, Tetreault L, Kalsi-Ryan S, Fehlings M. Psychometric properties of the modified Japanese Orthopaedic Association scale in patients with cervical spondylotic myelopathy. Spine (Phila Pa 1976). 2015 Jan 1;40(1):E23-8. doi: 10.1097/BRS.0000000000000648.  PMID: 25341993

Chair, thesis committee for Rachel Thompson
Perioperative risk of and monitoring for hyperglycemia

Chair, capstone for Jeffrey Wells
Growing research: The Development of a Hazardous Materials/Blood Borne Pathogen Protocol

Chair, thesis committee for Susan Strom
Caesarean section birth rates in El Salvador: 1998 to 2008

Chair, thesis committee for Dimitrinka Tamneva
To examine prevalence of maternal smoking before, during, and after-pregnancy as documented in the Washington State and national PRAMS datasets in 2000 through 2008

An Assessment of Surgical Techniques for Treating Cervical Spondylotic An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy. International Multicenter Study
University Health Network, Canada
PI:   Kopjar           Dates:    4/1/2011 - 12/31/2016

Riluzole in Spinal Cord Injury Study (RISCIS)

The aim of this study is to evaluate efficacy and safety of riluzole in the treatment of patients with acute spinal cord injury (SCI).

Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)

Study of the efficacy of Riluzole in patients with cervical spondylotic myelopathy undergoing surgical treatment. A randomized, double-blind, placebo-controlled multi-center study